Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBVX.L Share News (BVX)

  • There is currently no data for BVX

BVX.L News

IN BRIEF: Bivictrix selects clinical candidate for leukaemia trial
6 Jun 2023

IN BRIEF: Bivictrix selects clinical candidate for leukaemia trial

Bivictrix Therapeutics PLC - Macclesfield, England-based biotechnology company focusing on cancer therapies - Nominates a clinical candidate for its B...

EARNINGS UPDATES: Ironveld sees interim pretax loss widen on costs
30 Mar 2023

EARNINGS UPDATES: Ironveld sees interim pretax loss widen on costs

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

EXECUTIVE CHANGES: Record founder retires; Bivictrix appoints new CFO
1 Mar 2023

EXECUTIVE CHANGES: Record founder retires; Bivictrix appoints new CFO

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported...

TRADING UPDATES: Bivictrix hails cancer therapy candidate
31 Jan 2023

TRADING UPDATES: Bivictrix hails cancer therapy candidate

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Michael Kauffman promoted to BiVictriX board chair
6 Jan 2023

Michael Kauffman promoted to BiVictriX board chair

(Sharecast News) - Cancer therapy developer BiVictriX Therapeutics announced on Friday that Dr Michael Kauffman has been appointed as its non-executiv...

Bivictrix promotes non-executive director to non-executive chair
6 Jan 2023

Bivictrix promotes non-executive director to non-executive chair

(Alliance News) - Bivictrix Therapeutics PLC on Friday said it promoted its non-executive director to non-executive chair.

BiVictriX identifies development lead for potential cancer drug
7 Dec 2022

BiVictriX identifies development lead for potential cancer drug

(Sharecast News) - Cancer therapy-focussed biotechnology company BiVictriX Therapeutics has identified a development lead for its 'BVX001' programme, ...